中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2013年
23期
1445-1449
,共5页
韩文恒%张逊%徐美林%王菁%韩兴鹏%孙伟
韓文恆%張遜%徐美林%王菁%韓興鵬%孫偉
한문항%장손%서미림%왕정%한흥붕%손위
Cdc42%WAVE1%非小细胞肺癌%免疫组织化学
Cdc42%WAVE1%非小細胞肺癌%免疫組織化學
Cdc42%WAVE1%비소세포폐암%면역조직화학
Cdc42%WAVE1%non-small cell lung cancer%immunohistochemistry
目的:探讨Cdc42和WAVE1在非小细胞肺癌(NSCLC)中的表达及其临床意义。方法:采用免疫组织化学法检测106例经石蜡包埋的NSCLC组织及46例癌旁正常肺组织中Cdc42和WAVE1的表达情况。结果:Cdc42和WAVE1在NSCLC组织中的表达明显高于正常肺组织。Cdc42的表达强度与肿瘤的分化程度、TNM分期及淋巴结转移情况之间差异有统计学意义(P<0.05);WAVE1的表达强度与TNM分期及淋巴结转移情况之间差异有统计学意义(P<0.05或P<0.01)。NSCLC组织中Cdc42和WAVE1的表达呈正相关(r=0.469,P<0.01)。Cdc42高表达组的3年生存率(44.16%)低于低表达组(72.41%),WAVE1高表达组的3年生存率(39.44%)亦低于低表达组(77.14%),且差异均有统计学意义(P<0.01)。淋巴结转移、Cdc42和WAVE1共同高表达是影响NSCLC患者预后的独立因素。结论:Cdc42和WAVE1在NSCLC组织中异常高表达,且呈现较好的相关性,可能共同参与并促进NSCLC的恶性进程,检测两者的表达会对NSCLC患者的临床病理学特征及预后起一定的提示作用。
目的:探討Cdc42和WAVE1在非小細胞肺癌(NSCLC)中的錶達及其臨床意義。方法:採用免疫組織化學法檢測106例經石蠟包埋的NSCLC組織及46例癌徬正常肺組織中Cdc42和WAVE1的錶達情況。結果:Cdc42和WAVE1在NSCLC組織中的錶達明顯高于正常肺組織。Cdc42的錶達彊度與腫瘤的分化程度、TNM分期及淋巴結轉移情況之間差異有統計學意義(P<0.05);WAVE1的錶達彊度與TNM分期及淋巴結轉移情況之間差異有統計學意義(P<0.05或P<0.01)。NSCLC組織中Cdc42和WAVE1的錶達呈正相關(r=0.469,P<0.01)。Cdc42高錶達組的3年生存率(44.16%)低于低錶達組(72.41%),WAVE1高錶達組的3年生存率(39.44%)亦低于低錶達組(77.14%),且差異均有統計學意義(P<0.01)。淋巴結轉移、Cdc42和WAVE1共同高錶達是影響NSCLC患者預後的獨立因素。結論:Cdc42和WAVE1在NSCLC組織中異常高錶達,且呈現較好的相關性,可能共同參與併促進NSCLC的噁性進程,檢測兩者的錶達會對NSCLC患者的臨床病理學特徵及預後起一定的提示作用。
목적:탐토Cdc42화WAVE1재비소세포폐암(NSCLC)중적표체급기림상의의。방법:채용면역조직화학법검측106례경석사포매적NSCLC조직급46례암방정상폐조직중Cdc42화WAVE1적표체정황。결과:Cdc42화WAVE1재NSCLC조직중적표체명현고우정상폐조직。Cdc42적표체강도여종류적분화정도、TNM분기급림파결전이정황지간차이유통계학의의(P<0.05);WAVE1적표체강도여TNM분기급림파결전이정황지간차이유통계학의의(P<0.05혹P<0.01)。NSCLC조직중Cdc42화WAVE1적표체정정상관(r=0.469,P<0.01)。Cdc42고표체조적3년생존솔(44.16%)저우저표체조(72.41%),WAVE1고표체조적3년생존솔(39.44%)역저우저표체조(77.14%),차차이균유통계학의의(P<0.01)。림파결전이、Cdc42화WAVE1공동고표체시영향NSCLC환자예후적독립인소。결론:Cdc42화WAVE1재NSCLC조직중이상고표체,차정현교호적상관성,가능공동삼여병촉진NSCLC적악성진정,검측량자적표체회대NSCLC환자적림상병이학특정급예후기일정적제시작용。
Objective:To investigate the expression and clinical significance of cell division cycle 42 (Cdc42) and WASP family verprolin-homologous protein l (WAVE1) in non-small cell lung cancer (NSCLC). Methods:The expression of Cdc42 and WAVE1 was detected in 106 paraffin-embedded NSCLC tissues and 46 adjacent normal lung tissues (control group) using immunohistochemis-try. Results:The expression levels of Cdc42 and WAVE1 was distinctly higher in NSCLC than in the control group. The expression of Cdc42 in NSCLC significantly correlated with tumor differentiation, TNM stage, and lymph node metastasis (P<0.05). The expression of WAVE1 in NSCLC was significantly correlated with TNM stage and lymph node metastasis (P<0.05 or P<0.01). The expression of Cdc42 was significantly correlated with WAVE1 in NSCLC (r=0.469, P<0.01). The 3-year survival rates were significantly lower in the group with high Cdc42 expression (44.16%) than in the low expression group (72.41%;P<0.01). Similarly, the 3-year survival rates were significantly lower among patients with high WAVE1 expression (39.44%) than in those with low expression (77.14%;P<0.01). Lymph node metastasis and the common high Cdc42 and WAVE1 expression were independent prognostic factors for NSCLC. Conclu-sion:The Cdc42 expression is correlated with WAVE1 expression. They may act together and have an important function in NSCLC. The expression of both Cdc42 and WAVE1 in NSCLC tissue may be used as markers for assessing the clinicopathologic features and prognosis.